Salt forms of poorly soluble probucol esters and ethers

Details Salt forms of poorly soluble probucol esters and ethers Salt forms of poorly soluble probucol esters and ethers

2008-05-13

2008-05-13

Puttlitz, Karl (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

C562S427000, C514S732000, C514S738000

Reexamination Certificate

active

07371895

ABSTRACT:
Organic amine salts of compounds of the formula:and their pharmaceutically acceptable salts, and uses in medical therapy are provided.

REFERENCES:
patent: 4522811 (1985-06-01), Epstein et al.
patent: 4954514 (1990-09-01), Kita et al.
patent: 5155250 (1992-10-01), Parker et al.
patent: 5262439 (1993-11-01), Parthasarathy
patent: 5608095 (1997-03-01), Parker et al.
patent: 6121319 (2000-09-01), Somers
patent: 6147250 (2000-11-01), Somers
patent: 6852878 (2005-02-01), Meng et al.
patent: 6960683 (2005-11-01), Meng
patent: 2001/0029660 (2001-10-01), Johnson
patent: 2001/0032014 (2001-10-01), Yang et al.
patent: 2004/0204485 (2004-10-01), Sikorski et al.
patent: 2005/0065121 (2005-03-01), Sikorski et al.
patent: 2005/0171028 (2005-08-01), Meng et al.
patent: 2005/0267187 (2005-12-01), Weingarten
patent: 2006/0020038 (2006-01-01), Meng et al.
patent: 0348203 (1989-12-01), None
patent: 0405788 (1991-01-01), None
patent: 2130975 (1972-11-01), None
patent: 2133024 (1972-11-01), None
patent: 2134810 (1972-12-01), None
patent: 2140769 (1973-01-01), None
patent: 2140771 (1973-01-01), None
patent: 2168137 (1973-08-01), None
patent: WO 95/15760 (1995-06-01), None
patent: WO 01/70757 (2001-09-01), None
Brown, L., et al., “Transdermal Delivery of Drugs,”Ann. Rev. Med., 39:221-229 (1988).
Kaplan, N.M. “Chapter 26: Systemic hypertension: mechanisms and diagnosis,” inHeart Disease, 5thed., Braunwald, E., Ed. (W.B. Saunders & Co., Philadelphia, 1997), pp. 807-823.
Meng, C.Q., et al., “Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis,”Bioorg. Med. Chem. Ltrs., 12(18):2545-2548 (2002).
Sundell, C., et al., “AGIX-4207: A novel antioxidant and anti-inflammatory compound inhibits progression of collagen II arthritis in the rat,”FASEB Journal, 16(4): A182 (Apr. 20-24, 2002), Annual Meeting of the Professional Research Scientists on Experimental Biology, ISSN 0892-6638.

Affiliated with

Also associated with

Rating

Salt forms of poorly soluble probucol esters and ethers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Salt forms of poorly soluble probucol esters and ethers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salt forms of poorly soluble probucol esters and ethers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2781416